Fourth, medication history for DM (insulin and oral hypoglycemic agent) and CVD prevention (such as statins, renin–angiotensin system blocking drugs, and beta-blockers) was not accounted in each study, which will influence the clinical outcomes of diabetic patients after PCI. This evidence concerns the gene INS and diabetes mellitus.